Prevalence and distribution of alcohol use and impairment in the workplace: a U.S. national survey

Journal of Studies on Alcohol
Michael R Frone

Abstract

Although much research has explored overall alcohol use in the workforce, little research has explored the extent of alcohol use and impairment in the workplace. This study explored the overall prevalence, frequency, and distribution of alcohol use and impairment during the workday. Data were collected from a national probability sample of 2805 employed adults using a random digit dialing telephone survey. Alcohol use within 2 hours of reporting to work, alcohol use during the workday, working under the influence of alcohol, and working with a hangover were assessed for the 12 months preceding the interview. Workplace alcohol use and impairment directly affect an estimated 15% of the U.S. workforce (19.2 million workers). Specifically, an estimated 1.83% (2.3 million workers) drink before work, 7.06% (8.9 million workers) drink during the workday, 1.68% (2.1 million workers) work under the influence of alcohol, and 9.23% (11.6 million workers) work with a hangover. The results also suggest that most workplace alcohol use and impairment occur infrequently. The distribution of workplace alcohol use and impairment differs by gender, race, age, marital status, occupation, and work shift. Workplace alcohol use and impairment are pre...Continue Reading

Citations

Dec 3, 2014·The Psychiatric Clinics of North America·R Gregory Lande
Sep 23, 2011·The Journal of Behavioral Health Services & Research·Alexander J CowellJesse M Hinde
Feb 26, 2010·The American Journal of Drug and Alcohol Abuse·Roland S MooreGenevieve M Ames
Sep 15, 2014·Experimental and Molecular Pathology·Manuela G NeumanSteve Malnick
Apr 15, 2014·Gaceta sanitaria·Lucía Moure-RodríguezFernando Cadaveira
Jun 22, 2011·AAOHN Journal : Official Journal of the American Association of Occupational Health Nurses·Sonia A DuffyOiSaeng Hong
Dec 19, 2015·Journal of Occupational Medicine and Toxicology·Hilde Marie Erøy EdvardsenHallvard Gjerde
Sep 11, 2007·American Journal of Preventive Medicine·Timothy S NaimiChetna Mehrotra
Jun 30, 2007·Journal of Substance Abuse Treatment·Diana M Doumas, Elizabeth Hannah
Apr 7, 2009·Human Psychopharmacology·Gemma PratMiquel Sánchez-Turet
Dec 5, 2008·Alcoholism, Clinical and Experimental Research·Helen M PettinatiStephanie S O'Malley
Jul 19, 2011·Alcoholism, Clinical and Experimental Research·Brandon M RobertsonAndrew C Heath
Jun 30, 2011·Addiction·Ken PiddFemke Buisman-Pijlman
Sep 17, 2013·Alcoholism, Clinical and Experimental Research·Janne S TolstrupMorten Grønbaek
May 20, 2014·Psychiatry Journal·Steven L Proctor, Philip L Herschman
Jul 30, 2014·PloS One·Susanna AwoliyiVictor R Preedy
Dec 14, 2006·Journal of Public Health Policy·Jonathan HowlandJacey Greece
Jul 9, 2016·Journal of Occupational and Environmental Medicine·Melissa K RichmondAna P Nunes
Aug 2, 2012·Advances in Preventive Medicine·J C Verster, O Berthélemy
May 21, 2013·Journal of Workplace Behavioral Health·Michael R DukeCarol B Cunradi
Feb 7, 2012·Psychology & Health·Thomas Conway, Pádraig MacNeela
Oct 25, 2011·American Journal of Public Health·Paul A SchulteHeeKyoung Chun
Sep 12, 2014·Psychodynamic Psychiatry·William H Sledge, Susan G Lazar
Sep 6, 2012·Scandinavian Journal of Public Health·Thor NorströmHåkan Leifman
Aug 17, 2011·International Journal of Environmental Research and Public Health·Alain MarchandMarie-Ève Blanc
Nov 19, 2013·International Journal of Environmental Research and Public Health·Marizen RamirezCorinne Peek-Asa
Sep 16, 2017·International Journal of Environmental Research and Public Health·Pablo RuisotoIván Fernández-Suárez
Apr 16, 2019·Journal of Occupational and Environmental Medicine·Martin StepanekFrancois Millard
Jun 27, 2020·Minerva cardioangiologica·Shu HuRoberto Cotellese
May 3, 2020·Journal of Occupational and Environmental Medicine·Devan HawkinsDavid Kriebel
Jul 4, 2020·Substance Use & Misuse·Taylor M Shockey, Marissa B Esser
Jul 25, 2020·Addiction·Inger Synnøve Moan, Torleif Halkjelsvik
Jun 2, 2017·Human Psychopharmacology·Ranil JayawardenaJoris C Verster
Apr 11, 2018·International Journal of Mental Health Systems·Oliva NalwaddaFred Kigozi

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.